UKSPA News

Oxford Gene Technology (OGT), has developed a breakthrough targeted NGS panel for constitutional cytogenetics research.

The new CytoSure™ NGS panel—launching early in 2020—will combine the strengths of microarrays and NGS to deliver a comprehensive all-in-one assay.

The new panel, in conjunction with OGT’s popular Interpret analysis software facilitates the accurate and confident detection of loss of heterozygosity (LOH), mosaicism and copy number variants (CNVs), in addition to those more traditionally assayed by NGS, single nucleotide variants (SNVs) and insertions/deletions (indels).

11/12/19

Member Related To This Article

Cambridge Science Park

View Profile

BioEscalator, the University of Oxford’s Biomedical Incubator, Launches New Video Campaign

Learn More

University of Warwick Science Park Announces Appointment of Centre Manager at Blythe Valley Innovation Centre

Learn More

Alexandra Daisy Ginsberg makes a moth’s hidden world visible in major new public artwork at Oxford North

Learn More

Business Accelerator Behind £75m in Start-up Funding Calls for Next Wave of Entrepreneurs

Learn More

Oxford North claims another honour with Best Commercial Building win

Learn More

Subscribe to Our Newsletter to Keep Up to Date With the Latest UKSPA News

UKSPA
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.